Telangana DCA launches SMS alert system to notify NSQ drugs

Hyderabad: The Drugs Control Administration (DCA) in Telangana has significantly intensified its crackdown on illegal medical practices while simultaneously launching a high-tech digital shield for public health.

On March 9, the agency officially rolled out a Bulk SMS Alert System designed to instantly notify medical establishments across the state about ‘Not of Standard Quality’ (NSQ) drugs. This dual approach of field enforcement and digital transparency marks a major shift in how the state monitors pharmaceutical safety.

The new Bulk SMS Alert System serves as a rapid-response mechanism to withdraw substandard medicines from the market before they reach patients. By sending immediate alerts to all retail pharmacies and wholesalers, the DCA can now facilitate the swift recall of drugs that have failed critical quality tests, such as assay or disintegration. Telangana has emerged as one of the few states in India to implement such a proactive regulatory tool.

Evidence of the system’s immediate application was seen in an alert issued for ‘ZOFMOX-CV Syrup’ (Batch No. JMD-250326D), which was declared substandard and flagged for an immediate stop-sale. This digital transformation ensures that critical safety information is no longer delayed by traditional communication channels, providing real-time protection for consumers.

Parallel to these digital efforts, DCA officials conducted a successful raid on an illegal medical facility in Jadalapet Village in Chityal Mandal. The operation targeted a clinic operated by an unqualified practitioner, Bayagani Venkanna, who was found practicing medicine without any valid qualifications. This enforcement action underscores the agency’s commitment to rooting out quackery that endangers rural communities.

During the raid, officials seized 50 varieties of illegally stocked medicines, including antibiotics, steroids, and physician’s samples. The total value of the confiscated stock was estimated at Rs. 45,000. The presence of these potent drugs in the hands of an unqualified individual poses a severe risk, as misuse can lead to hormonal imbalances and the dangerous rise of antimicrobial resistance.

In the wake of these events, the DCA has issued a stern advisory to all pharmaceutical wholesalers and dealers. Under the Drugs and Cosmetics Act, 1940, supplying medicines to unqualified persons or unlicensed shops is a strictly punishable offense. Authorities emphasized that it is the legal responsibility of every distributor to verify the licenses of their recipients before completing any supply.

Director General of the DCA, Shahnawaz Qasim, encouraged the public to remain vigilant and report any suspicious manufacturing or illegal drug sales. People can utilize the DCA Telangana toll-free number, 1800-599-6969, to file complaints during working hours. Through the combination of strict field raids and the new SMS alert system, the state aims to build a more transparent and secure healthcare environment, said S Ramdan, joint drug controller.

Related Posts

Apollo Navi Mumbai launches geriatric oncology clinic

With a dedicated Geriatric Oncology Clinic, Apollo Hospitals Navi Mumbai brings specialised geriatric cancer care to the private healthcare setting in Navi Mumbai. With the launch of the Geriatric Oncology…

Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

Mumbai: The Food and Drug Administration (FDA) has cracked down on medical stores violating drug-sale rules, suspending 599 licences and cancelling another 141 after inspecting 2,295 retail establishments across the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Apollo Navi Mumbai launches geriatric oncology clinic

Apollo Navi Mumbai launches geriatric oncology clinic

Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

Himachal DCA honoured with ‘Regulatory Excellence Award’ at iPHEX 2026

Himachal DCA honoured with ‘Regulatory Excellence Award’ at iPHEX 2026

Baddi pharma firm loses licence after 1,200-kg tapentadol haul

Baddi pharma firm loses licence after 1,200-kg tapentadol haul

US FDA takes steps to maintain newborn access to life-saving starter nutrition products

US FDA takes steps to maintain newborn access to life-saving starter nutrition products

Mankind Pharma launches campaign to inspire 1 crore Indians to pledge for organ donation